Insulin Resistance is Associated with MCP1-Mediated Macrophage Accumulation in Skeletal Muscle in Mice and Humans
Open accessThe DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Inflammation is now recognized as a major factor contributing to type 2 diabetes (T2D). However, while the mechanisms and consequences associated with white adipose tissue inflammation are well described, very little is known concerning the situation in skeletal muscle. The aim of this study was to investigate, in vitro and in vivo, how skeletal muscle inflammation develops and how in turn it modulates local and systemic insulin sensitivity in different mice models of T2D and in humans, focusing on the role of the chemokine MCP1. Here, we found that skeletal muscle inflammation and macrophage markers are increased and associated with insulin resistance in mice models and humans. In addition, we demonstrated that intra-muscular TNFα expression is exclusively restricted to the population of intramuscular leukocytes and that the chemokine MCP1 was associated with skeletal muscle inflammatory markers in these models. Furthermore, we demonstrated that exposure of C2C12 myotubes to palmitate elevated the production of the chemokine MCP1 and that the muscle-specific overexpression of MCP1 in transgenic mice induced the local recruitment of macrophages and altered local insulin sensitivity. Overall our study demonstrates that skeletal muscle inflammation is clearly increased in the context of T2D in each one of the models we investigated, which is likely consecutive to the lipotoxic environment generated by peripheral insulin resistance, further increasing MCP1 expression in muscle. Consequently, our results suggest that MCP1-mediated skeletal muscle macrophages recruitment plays a role in the etiology of T2D.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While a report shows that local inflammation induced by muscle MCP-1 overexpression interferes with insulin signaling in muscle [60], the other study does not report a similar observation [61].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“In the present study, we observed that within skeletal muscle, TNFa expression is almost exclusive to CD45+ cells, which is comparable to the situation in the WAT, where TNFa expression is more prevalent in the stromal vascular fraction [13].”
BackgroundObesity induces a phenotypic switch in adipose tissue macrophage polarization
Lumeng, C. N., Bodzin, J. L., & Saltiel, A. R. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29881 · Cited by 4,664 · cited 1×
“0–5 pg/ml for TNFa) [2,9,11,12] and recently, it was shown that larger molecules such as the TNFa inhibitor etanercept, fails to improve insulin sensitivity [2].”
BackgroundMacrophages, inflammation, and insulin resistance
Olefsky, J. M., & Glass, C. K. (2010) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021909-135846 · Cited by 2,733
Kanda, H. (2006) · Journal of Clinical Investigation · doi:10.1172/jci26498 · Cited by 2,682
Inflammatory links between obesity and metabolic disease
Lumeng, C. N., & Saltiel, A. R. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57132 · Cited by 2,319 · cited 1×
“Interestingly, TNFa is a pro-inflammatory cytokine that not only promotes insulin resistance [29,40], it also induces sarcopenia [41].”
BackgroundArnold, L., Henry, A., Poron, F., Baba-Amer, Y., van Rooijen, N., Plonquet, A., Gherardi, R. K., & Chazaud, B. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070075 · Cited by 2,002
Insulin sensitivity: Modulation by nutrients and inflammation
Schenk, S., Saberi, M., & Olefsky, J. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci34260 · Cited by 1,191 · cited 1×
“tion observed in response to rosiglitazone administration was supportive of the notion that skeletal muscle triglycerides content and insulin resistance can be disconnected, such as seen in several models [25–27].”
Suganami, T., Nishida, J., & Ogawa, Y. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000183883.72263.13 · Cited by 1,056 · cited 2×
“As such, ablation of the F4/80+ CD11b+CD11c+, macrophages, which mediate at least some of the diabetogenic properties of fatty acids, improves insulin sensitivity at both systemic and skeletal muscle levels [6,8–10].”
BackgroundResultKamei, N., Tobe, K., Suzuki, R., Ohsugi, M., Watanabe, T., Kubota, N., Ohtsuka-Kowatari, N., Kumagai, K., Sakamoto, K., Kobayashi, M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601284200 · Cited by 917
Ye, J., Gao, Z., Yin, J., & He, Q. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00435.2007 · Cited by 840
Accelerated Loss of Skeletal Muscle Strength in Older Adults With Type 2 Diabetes
Park, S. W., Goodpaster, B. H., Strotmeyer, E. S., Kuller, L. H., Broudeau, R., Kammerer, C., de Rekeneire, N., Harris, T. B., Schwartz, A. V., Tylavsky, F. A., et al. (2007) · Diabetes Care · doi:10.2337/dc06-2537 · Cited by 766 · cited 1×
“Sarcopenia is itself associated with aging and worsened by T2D and inflammation [39].”
BackgroundSaturated Fatty Acid and TLR Signaling Link β Cell Dysfunction and Islet Inflammation
Eguchi, K., Manabe, I., Oishi-Tanaka, Y., Ohsugi, M., Kono, N., Ogata, F., Yagi, N., Ohto, U., Kimoto, M., Miyake, K., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.01.023 · Cited by 519
Medina-Gomez, G., Gray, S. L., Yetukuri, L., Shimomura, K., Virtue, S., Campbell, M., Curtis, R. K., Jimenez-Linan, M., Blount, M., Yeo, G. S. H., et al. (2007) · PLoS Genetics · doi:10.1371/journal.pgen.0030064 · Cited by 430
Liu, L., Zhang, Y., Chen, N., Shi, X., Tsang, B., & Yu, Y.-H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30565 · Cited by 356 · cited 1×
“tion observed in response to rosiglitazone administration was supportive of the notion that skeletal muscle triglycerides content and insulin resistance can be disconnected, such as seen in several models [25–27].”
The Protein Kinase IKKɛ Regulates Energy Balance in Obese Mice
Chiang, S.-H., Bazuine, M., Lumeng, C. N., Geletka, L. M., Mowers, J., White, N. M., Ma, J.-T., Zhou, J., Qi, N., Westcott, D., et al. (2009) · Cell · doi:10.1016/j.cell.2009.06.046 · Cited by 344
Phillips, T., & Leeuwenburgh, C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2870fje · Cited by 283
Lipid metabolome-wide effects of the PPARγ agonist rosiglitazone
Watkins, S. M., Reifsnyder, P. R., Pan, H.-J., German, J. B., & Leiter, E. H. (2002) · Journal of Lipid Research · doi:10.1194/jlr.m200169-jlr200 · Cited by 274
Regulation by Insulin of Gene Expression in Human Skeletal Muscle and Adipose Tissue
Ducluzeau, P.-H., Perretti, N., Laville, M., Andreelli, F., Vega, N., Riou, J.-P., & Vidal, H. (2001) · Diabetes · doi:10.2337/diabetes.50.5.1134 · Cited by 263
Self-citationLu, H., Huang, D., Saederup, N., Charo, I. F., Ransohoff, R. M., & Zhou, L. (2011) · The FASEB Journal · doi:10.1096/fj.10-171579 · Cited by 260
CCL5 Promotes Macrophage Recruitment and Survival in Human Adipose Tissue
Keophiphath, M., Rouault, C., Divoux, A., Clément, K., & Lacasa, D. (2010) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.197442 · Cited by 229
Varma, V., Yao-Borengasser, A., Rasouli, N., Nolen, G. T., Phanavanh, B., Starks, T., Gurley, C., Simpson, P., McGehee, R. E., Kern, P. A., et al. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90885.2008 · Cited by 229 · cited 1×
“Thirdly, increased inflammation was observed in skeletal muscles of murine models of T2D but also in obese subjects where pro-inflammatory macrophages infiltration correlated with patients BMI and age [22,23].”
BackgroundLaugerette, F., Furet, J.-P., Debard, C., Daira, P., Loizon, E., Géloën, A., Soulage, C. O., Simonet, C., Lefils-Lacourtablaise, J., Bernoud-Hubac, N., et al. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00314.2011 · Cited by 186
Self-citationPPARγ inhibits NF-κB-dependent transcriptional activation in skeletal muscle
Remels, A. H. V., Langen, R. C. J., Gosker, H. R., Russell, A. P., Spaapen, F., Voncken, J. W., Schrauwen, P., & Schols, A. M. W. J. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90632.2008 · Cited by 184
CXC Ligand 5 Is an Adipose-Tissue Derived Factor that Links Obesity to Insulin Resistance
Chavey, C., Lazennec, G., Lagarrigue, S., Clapé, C., Iankova, I., Teyssier, J., Annicotte, J.-S., Schmidt, J., Mataki, C., Yamamoto, H., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.03.002 · Cited by 182
Obesity-Related Upregulation of Monocyte Chemotactic Factors in Adipocytes
Jiao, P., Chen, Q., Shah, S., Du, J., Tao, B., Tzameli, I., Yan, W., & Xu, H. (2009) · Diabetes · doi:10.2337/db07-1344 · Cited by 166
Bosma, M., Hesselink, M. K. C., Sparks, L. M., Timmers, S., Ferraz, M. J., Mattijssen, F., van Beurden, D., Schaart, G., de Baets, M. H., Verheyen, F. K., et al. (2012) · Diabetes · doi:10.2337/db11-1402 · Cited by 149
Bravard, A., Lefai, E., Meugnier, E., Pesenti, S., Disse, E., Vouillarmet, J., Peretti, N., Rabasa-Lhoret, R., Laville, M., Vidal, H., et al. (2011) · Diabetes · doi:10.2337/db10-0281 · Cited by 124
Self-citationBouzakri, K., Plomgaard, P., Berney, T., Donath, M. Y., Pedersen, B. K., & Halban, P. A. (2011) · Diabetes · doi:10.2337/db10-1178 · Cited by 122
Fink, L. N., Oberbach, A., Costford, S. R., Chan, K. L., Sams, A. G., Blüher, M., & Klip, A. (2013) · Diabetologia · doi:10.1007/s00125-013-2897-x · Cited by 118
Tumor necrosis factor α signaling in skeletal muscle: effects of age and caloric restriction
Dirks, A. J., & Leeuwenburgh, C. (2005) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2005.11.002 · Cited by 114
Abshagen, K., Schrodi, I., Gerber, T., & Vollmar, B. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.32237 · Cited by 86
Lecomte, V., Meugnier, E., Euthine, V., Durand, C., Freyssenet, D., Nemoz, G., Rome, S., Vidal, H., & Lefai, E. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00690-09 · Cited by 80
Self-citationTakahashi, K., Yamaguchi, S., Shimoyama, T., Seki, H., Miyokawa, K., Katsuta, H., Tanaka, T., Yoshimoto, K., Ohno, H., Nagamatsu, S., et al. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00131.2007 · Cited by 77
Keratinocyte-derived Chemokine in Obesity
Neels, J. G., Badeanlou, L., Hester, K. D., & Samad, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018556 · Cited by 73
Rieusset, J., Chauvin, M., Durand, A., Bravard, A., Laugerette, F., Michalski, M., & Vidal, H. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.11.135 · Cited by 60
Self-citationPedersen, L., Olsen, C. H., Pedersen, B. K., & Hojman, P. (2012) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00339.2011 · Cited by 60
Regulation of Chemokine and Chemokine Receptor Expression by PPARγ in Adipocytes and Macrophages
Nguyen, M. T., Chen, A., Lu, W. J., Fan, W., Li, P., Oh, D. Y., & Patsouris, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0034976 · Cited by 53
Self-citationLow Macrophage Accumulation in Skeletal Muscle of Obese Type 2 Diabetics and Elderly Subjects
Tam, C. S., Sparks, L. M., Johannsen, D. L., Covington, J. D., Church, T. S., & Ravussin, E. (2012) · Obesity · doi:10.1038/oby.2012.24 · Cited by 45
Type 2 diabetes — who is conducting the orchestra?
Kahn, B. B., & Rossetti, L. (1998) · Nature Genetics · doi:10.1038/3018 · Cited by 36
Tomkowiak, M., Ghittoni, R., Teixeira, M., Blanquier, B., Szécsi, J., Négre, D., Aubert, D., Coupet, C., Brunner, M., Verhoeyen, E., et al. (2012) · genesis · doi:10.1002/dvg.22364 · Cited by 5
Research works printed but not linked: 1
- CS Tam, 2012, Low macrophage accumulation in skeletal muscle of obese type 2 diabetics and elderly subjects, Obesity (Silver Spring), 20, 1530, 10.1038/oby.2012.24 · DOI · Paper page
Cited by
Inflammation in obesity, diabetes, and related disorders
Rohm, T. V., Meier, D. T., Olefsky, J. M., & Donath, M. Y. (2022) · Immunity · doi:10.1016/j.immuni.2021.12.013 · Cited by 2,066
Chronic Adipose Tissue Inflammation Linking Obesity to Insulin Resistance and Type 2 Diabetes
Zatterale, F., Longo, M., Naderi, J., Raciti, G. A., Desiderio, A., Miele, C., & Beguinot, F. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01607 · Cited by 1,180
“These macrophages secrete many cytokines, which have been shown to trigger inflammatory pathways within myocyte, culminating in decreased insulin signaling (Varma et al., 2009; Pillon et al., 2012; Patsouris et al., 2014).”
BackgroundKalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882
Skeletal muscle inflammation and insulin resistance in obesity
Wu, H., & Ballantyne, C. M. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88880 · Cited by 695
Regulation of metabolism by the innate immune system
Lackey, D. E., & Olefsky, J. M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.189 · Cited by 667
Metadata
- Authors
- Patsouris, D., Cao, J.-J., Vial, G., Bravard, A., Lefai, E., Durand, A., Durand, C., Chauvin, M.-A., Laugerette, F., Debard, C., Michalski, M.-C., Laville, M., Vidal, H., & Rieusset, J.
- Affiliations
- Lyon 1 Université (FR)
- Corresponding author
- Patsouris, David
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2014-10-22
- Volume
- 9
- Issue
- 10
- Pages
- e110653
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4206428
- OpenAlex
- W1980660681
- Cited by
- 122
- References
- 40
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 8 · 2023: 19 · 2022: 17 · 2021: 9 · 2020: 14 · 2019: 8 · 2018: 13 · 2017: 7 · 2016: 8 · 2015: 8
- FWCI
- 5.81
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Agence Nationale de la Recherche (018-01, ANR-09-JCJC-0116, ANR-09-RPDOC-018-01)
- Institut National de la Santé et de la Recherche Médicale (ANR-09-RPDOC-018-01)
- Université de Lyon
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- insulin resistance, MCP-1, skeletal muscle inflammation, macrophage accumulation, type 2 diabetes, TNF-α, palmitate, lipotoxicity, chemokines, C2C12 myotubes
- MeSH terms
- Animals, Cell Line, Cell Movement, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Macrophages, Male, Mice, Inbred C57BL, Mice, Obese, Mice, Transgenic, Myositis, Muscle, Skeletal, Chemokine CCL2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.